Gorakhpur: Conventional smear microscopy, though widely used in India, misses detection of many tuberculosis (TB) cases, ...

In a new study in Nature Communications, researchers from around India have suggested that the key to outsmarting the ...

In recent years, the field of immunology has increasingly focused on the role of glycolipids and sphingolipids in the differentiation and function of innate immune cells, such as macrophages, ...

Biofabri and Bharat Biotech partner to advance MTBVAC, a tuberculosis vaccine, ensuring equitable access and manufacturing ...

Hyderabad: Biofabri, a global human vaccine development company that is part of the Zendal group, and Bharat Biotech ...

Dr Rajratna Waghmare, joint director of Health Services (tuberculosis and leprosy), said the spike in detected cases during the campaign reflects improved surveillance rather than a sudden surge in in ...

Biofabri, a global human vaccine development company that is part of the Zendal group, and Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and manufacturing, on ...

Biofabri & Bharat Biotech sign technology transfer agreement to advance global access to MTBVAC and support TB control efforts: Our Bureau, Bengaluru Tuesday, December 23, 2025, 1 ...

Dec. 14, 2025 Scientists are uncovering a new possibility behind long COVID’s stubborn symptoms: hidden infections that awaken or emerge alongside SARS-CoV-2. Evidence is mounting that viruses like ...

Transposon sequencing analyses reveal that among genomically diverse clinical Mycobacterium intracellulare strains and the type strain, 131 genes were comprehensively identified as universal essential ...

The agreement strengthens an existing partnership between the two companies and marks a key step towards establishing ...